Medizone International, Inc. – MZEI – Breaking Out – Up 20% in Early Trading

Medizone International, Inc. (MZEI.OB) is breaking out.

I have been showing my readers the path her for some time now.

The signs have been there and now we are in the middle of a HUGE break out.

I like to bring your attention to new events about a stock but in this case I want to bring your attention to the most recent press release and couple that with my September post that MZEI had the classic break out signals.

Last Week’s Press Release:

AsepticSureTM was announced to be in its third round of trials  to establish the precise protocols necessary in order to obtain maximum bactericidal action in combination with minimum turn-around times in keeping with normal hospital flow patterns.

A  development prototype is being finalized in order to conduct a full room scale hospital mock up.

MZEI announced its move to the OTCBB and concluded that move in record time this past summer.

A new  website displays an incredible video explaining the current state of affairs and this is MUST SEE TV!  http://medizoneint.com

An announcement has been made regarding a expectations of a potential partnership with a multinational corporation.

The potential multinational corporation is anticipated to be in the hospital sector for increased manufacturing capacity, sales and service. The target is to achieve profitability moving into mid-year 2010.

Initial Sales of AsepticSure

• Initial sales of AsepticSure are targeted before the end of 2009 with deliveries during the first quarter of 2010.
• Sales are expected to bring the company to a break-even cash flow.
• The initial production rates will be kept on the conservative side until the design proves reliable in the field and a dramatic increase in production would not offer significant risk.

I think it is incredibly important to understand what they are saying.

This stock took a tremendous rise yesterday.  I just want to RESTATE my advice from my last post —

As far as I am concerned this product is basically proven and it’s time to look at it as if you were a multi-national corporation.  Is this a company you would want to purchase?

I say absolutely and best to be in before the transaction occurs.

When you have a product for which there is a pent-up demand you have shareholder value.

Contact:
Medizone International, Inc. (OTC: MZEI)
144 Buena Vista
P.O. Box 742
Stinson Beach, CA 94970
Web: http://www.medizoneint.com
Telephone: 415-868-0300
Fax: 415-868-2344
Investor Relations 800-953-3350
E-mail: operations@medizoneint.com

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 200,000 144 restricted common shares by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This blog contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to,the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.